Patent · US Active

Pharmaceutical formulations

US8383114B2 · kind B2 · utility

26Cited by

32References

6Claims

0Family size

Assignee

AMGEN INC. · US

Inventors

Christopher James Sloey · Newbury Park, US
Camille Vergara · Calabasas, US
Jason Ko · Thousand Oaks, US
Tiansheng Li · Beijing, CN

Key dates

Filing date	Sep 29, 2008
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Sep 29, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0019
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.